YAP1 and hepatocellular carcinoma: As a consequence, inactivation of USP10 promoted YAP/TAZ ubiquitination and proteasome-mediated degradation, and inhibited hepatocellular carcinoma cell growth both in vitro and in xenografts (Zhu et al., 2020).